Focused On-demand Library for WASH complex subunit 4

Focused On-demand Libraries - Reaxense Collaboration

Explore the Potential with AI-Driven Innovation

This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.

The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.

In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.

Our high-tech, dedicated method is applied to construct targeted libraries.

Fig. 1. The sreening workflow of Receptor.AI

Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.

Our library stands out due to several important features:

The Receptor.AI platform compiles comprehensive data on the target protein, encompassing previous experiments, literature, known ligands, structural details, and more, leading to a higher chance of selecting the most relevant compounds.
Advanced molecular simulations on the platform help pinpoint potential binding sites, making the compounds in our focused library ideal for finding allosteric inhibitors and targeting cryptic pockets.
Receptor.AI boasts over 50 tailor-made AI models, rigorously tested and proven in various drug discovery projects and research initiatives. They are crafted for efficacy, dependability, and precision, all of which are key in creating our focused libraries.
Beyond creating focused libraries, Receptor.AI offers comprehensive services and complete solutions throughout the preclinical drug discovery phase. Our success-based pricing model minimises risk and maximises the mutual benefits of the project's success.

partner

Reaxense

upacc

Q2M389

UPID:

WASC4_HUMAN

Alternative names:

Strumpellin and WASH-interacting protein; WASH complex subunit SWIP

Alternative UPACC:

Q2M389; Q2NL83; Q8IW61; Q8N5W7; Q9NVD6; Q9UPW7

Background:

The WASH complex subunit 4, also known as Strumpellin and WASH-interacting protein, plays a pivotal role in cellular processes. It is a crucial component of the WASH core complex, acting as a nucleation-promoting factor (NPF) at endosome surfaces. Here, it recruits and activates the Arp2/3 complex to induce actin polymerization, essential for the fission of tubules that facilitate endosome sorting.

Therapeutic significance:

Linked to Intellectual developmental disorder, autosomal recessive 43, WASH complex subunit 4's genetic variants underscore its clinical relevance. Understanding its role could unveil novel therapeutic strategies.